« Higbee Denies Class Cert for N.J. Vioxx Users | Main | Split FDA into Separate Food Administration and Drug Administration? »
March 20, 2009
Albany Law School Symposium on Off-Label Prescription of Drugs
As I previously briefly noted, Albany Law School is hosting on Friday, March 27 a symposium entitled, Regulating the Cure: Topics Arising Out of the Prescription of Drugs Off-Label. I will be speaking about liability from off-label promotion of drugs. Other participants include Dean Thomas Guernsey (Albany Law); Professors Beverly Cohen (Albany Law), Michael Kane (Albany College of Pharmacy & Health Sciences), Alicia Ouellette (Albany Law), Sarah Scarpace (Albany College of Pharmacy & Health Sciences), and Dan Thompson (Alden March Bioethics Institute); Mollie Hertel (U.S. Government Accountability Office); and practitioners Eric Chaffin (Bernstein Liebhard), Arnold Friede (McDermott, Will & Emery), Patrick Igoe (Registered Patent Attorney), and Raul Tabora (Ruffo, Tabora). Here's a link to the brochure.
BGS
March 20, 2009 in Conferences, FDA, Mass Tort Scholarship, Pharmaceuticals - Misc. | Permalink
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341bfae553ef01156f2a0734970b
Listed below are links to weblogs that reference Albany Law School Symposium on Off-Label Prescription of Drugs:
